Jagsonpal Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 601.53 million compared to INR 605.97 million a year ago. Revenue was INR 621.5 million compared to INR 609.11 million a year ago.

Net income was INR 74.79 million compared to INR 29.21 million a year ago. Basic earnings per share from continuing operations was INR 2.85 compared to INR 1.12 a year ago. Diluted earnings per share from continuing operations was INR 2.85 compared to INR 1.12 a year ago.